Loading…
Predictive factors and impact of full donor T-cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation
* Unite de Transplantation et de Therapie Cellulaire (UTTC), Institut Paoli-Calmettes, Marseille, France ° Université de la Méditerranée, Faculté de Médecine, Marseille, France; # INSERM, UMR 599, Marseille, France; @ Laboratoire dImmunologie, Hopital Saint-Eloi, CHU de Montpellier, Montpellier, Fr...
Saved in:
Published in: | Haematologica (Roma) 2007-07, Vol.92 (7), p.1004-1006 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | * Unite de Transplantation et de Therapie Cellulaire (UTTC), Institut Paoli-Calmettes, Marseille, France
° Université de la Méditerranée, Faculté de Médecine, Marseille, France;
# INSERM, UMR 599, Marseille, France;
@ Laboratoire dImmunologie, Hopital Saint-Eloi, CHU de Montpellier, Montpellier, France;
^ Département dOncologie Médicale, Institut Paoli-Calmettes, Marseille, France DB and JFE share senior authorship
Correspondence: Mohamad Mohty, M.D., Ph.D., Institut Paoli-Calmettes, 232 Bd. Ste Marguerite, F-13273 Marseille Cedex 09, France. Phone: international +33 491 223823; Fax: international +33 491 223579. E-Mail: mohtym{at}marseille.fnclcc.fr
This study investigated the kinetics of CD3+-T cell chimerism (TCC) in 102 patients receiving reduced intensity conditioning allogeneic stem cell transplantation (RIC-allo-SCT) from an HLA-identical sibling. Patients with full donor TCC at day 30 had a higher incidence of grade 2–4 acute GVHD compared to patients in mixed TCC (cumulative-incidence, 61% vs. 35%; p =0.01). The delayed establishment of full donor TCC in myeloid malignancies was associated with a higher incidence of relapse (40% vs. 0; p =0.002), suggesting that monitoring of the kinetics of TCC is mandatory after RIC-allo-SCT. |
---|---|
ISSN: | 0390-6078 1592-8721 |
DOI: | 10.3324/haematol.10971 |